Lv0
0 积分 2025-03-23 加入
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
已完结
Perioperative nivolumab results in favourable long-term outcomes in patients with locally advanced resectable non-small-cell lung cancer
1天前
已完结
Checkpoint Inhibitors Up Survival in Early-Stage Lung Cancer
1天前
已完结
Real-World Experience Favors a Neoadjuvant Strategy of Chemoimmunotherapy for Locoregionally Advanced NSCLC
1天前
已完结
皖公网安备34019202002308
